Skip to main content

Oral Rehydration Salts Market Size Worth USD 98.37 Million in 2032 | Emergen Research

Rising prevalence of dehydration-related issues is one of the major factors driving Oral Rehydration Salts (ORS) market revenue growth

Vancouver, Jan. 18, 2024 (GLOBE NEWSWIRE) — The global Oral Rehydration Salts (ORS) market size was USD 69.40 Million in 2022 and is expected to register a revenue CAGR of 3.6% during the forecast period, according to latest analysis by Emergen Research. Diarrheal diseases, whether caused by infections, foodborne illnesses, or other factors, often lead to excessive fluid loss, posing a substantial risk of dehydration which is a primary factor driving market revenue growth. For instance, according to World Health Organization, Diarrhea is the second largest cause of death in children under the age of five. Diarrhea kills approximately 525 000 children under the age of five each year and over 1.7 billion children suffer from diarrhea every year, globally which as a result is driving market revenue growth.

Rising prevalence of dehydration-related issues is another factor driving market revenue growth. Oral rehydration solutions are used to treat diarrheal dehydration, the constituent ratio in an ORS corresponds to what the body requires to recover from a diarrheal sickness. These are used to replenish the salts and water lost by the body as a result of dehydration induced by gastroenteritis, diarrhea, or vomiting hence driving market revenue growth.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2729

However, overconsumption of ORS can lead to an imbalance of electrolytes, particularly sodium which is a key factor hindering market revenue growth. Excessive sodium intake can have adverse effects on health, such as high blood pressure and other cardiovascular issues. Moreover, the presence of alternative hydration products, such as sports drinks, electrolyte-enhanced beverages, and Do It Yourself (DIY) rehydration solutions, can divert consumer preferences away which is another factor hampering market revenue growth.

Scope of Research

Report DetailsOutcome
Market size in 2022USD 69.40 Million
CAGR (2023–2032)3.6%
Revenue forecast to 2032USD  98.37 Million
Base year for estimation2022
Historical data2019–2021
Forecast period2023–2032
Quantitative unitsRevenue in USD Million and CAGR in % from 2023 to 2032
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments coveredORS Type, Form, Packaging Indication, Age Group, Distribution Channel, and Region.
Regional scopeNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
Country scopeU.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Benelux, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, South Africa, Turkey, Rest of MEA
Key companies profiledCera Products Inc., SIX SIGMA LABORATORIES, Abbott Laboratories, Trifecta Pharmaceuticals USA, LLC, Sanofi, Halewood Laboratories Pvt. Ltd, AdvaCare Pharma, H2ORS, INC., Drip Drop Hydration Inc., RecoverORS, GoHydrate, Precision Hydration Ltd, Fluid Tactical, GSK plc, Johnson & Johnson Services, Inc., Nestlé, Himalaya Wellness Company, Merck & Co., Inc., Lupin, Ajanta Pharma Ltd.
Customization scope10 hours of free customization and expert consultation

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @

https://www.emergenresearch.com/request-discount/2729

Major Companies and Competitive Landscape

The Oral Rehydration Salts (ORS) market is fragmented with large and medium-sized market players accounting for the majority of revenue. Major players are deploying various strategies, entering into mergers and acquisitions, strategic agreements and contracts, developing, testing, and introducing more effective in the market. Some major players included in the market report are:

  • Distribution Channe
  • Cera Products Inc
  • SIX SIGMA LABORATORIES
  • Abbott Laboratories
  • Trifecta Pharmaceuticals USA, LLC
  • Sanofi
  • Halewood Laboratories Pvt. Ltd
  • AdvaCare Pharma
  • H2ORS, INC
  • Drip Drop Hydration Inc
  • RecoverORS
  • GoHydrate
  • Precision Hydration Ltd
  • Fluid Tactical
  • GSK plc
  • Johnson & Johnson Services, Inc
  • Nestlé
  • Himalaya Wellness Company
  • Merck & Co., Inc
  • Lupin
  • Ajanta Pharma Ltd.

Strategic Development

  • On 24 January 2022, UFlex’Asepto, the first Indian manufacturer of Aseptic Liquid Packaging, has been chosen as the packaging partner of the FDC brand ‘Electral Z+ (ORS+Zinc Solution)’ ready-to-drink OTC product, which was made by Halewood Laboratories Private Ltd. The new value-added Electral variation featured in Asepto’s holographic packets is accessible in pharmacies and health centers throughout India. The six-layer packaging prevents bacteria, light, and air from contaminating the liquid ORS packaged and keeps the product contents sterile, as a result, the ORS solution has a long shelf life because no preservatives are used.
  • On 26 August 2020, DripDrop Hydration, a rehydration therapy company, announced the addition of an 80-count multi-flavor package of Berry, Lemon, Watermelon, and Orange flavors to their Oral Rehydration Solution (ORS) lineup. This was the addition to DripDrop’s armoury focused at fighting dehydration, which affects up to 75% of the US population.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @

https://www.emergenresearch.com/select-license/2729

Some Key Highlights From the Report

  • Standard ORS segment accounted for the largest market share in terms of revenue in 2022. Rising demand for Standard oral rehydration salts as it provides benefits and widespread applications, particularly in the management of dehydration which is a key factor driving revenue growth of the segment. The balanced combination of electrolytes, such as sodium, potassium, and chloride, along with glucose or other sugars, facilitates optimal water absorption in the intestines, thereby restoring fluid balance efficiently. Moreover, the timely administration prevents complications associated with dehydration, including kidney issues, electrolyte imbalances, and cardiovascular problems which is also contributing to revenue growth of the segment. Standard ORS is versatile, catering to different age groups, from infants to the elderly.
  • Tablet segment accounted for the largest market share in terms of revenue in 2022. Rising demand for ORS tablets as it offers a compact and lightweight solution ideal for individuals during travel or emergencies which is a key factor driving revenue growth of the segment. The pre-measured dosage provided by tablets ensures precision in electrolyte balance during rehydration. Tablets are also easy to store, requiring less space, and have an extended shelf life, contributing to the stability of the ORS formulation over time hence contributing to revenue growth of the segment.
  • The Asia Pacific market accounted for the largest revenue share in 2022. Rising demand for ORS among individuals as it is used to treat dehydration caused by conditions such as diarrhea and vomiting is the primary factor driving revenue growth of the market in this region. Education campaigns and advertisements regarding the importance of oral rehydration therapy is another factor influencing consumer behavior which as a result is boosting revenue growth of the market in this region.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@

https://www.emergenresearch.com/industry-report/oral-rehydration-salts-market

Emergen Research has segmented global Search Engine Optimization (SEO) market on the basis of ORS type, form, packaging Indication, age group, distribution channel, and region:

  • ORS Type Outlook (Revenue, USD Million; 2019–2032)
    • Standard ORS
    • ORS with zinc
    • low-Osmolarity ORS
    • Rice-Based ORS
  • Form Outlook (Revenue, USD Million; 2019–2032)
    • Tablet
    • Powder
    • Liquid
  • Packaging Outlook (Revenue, USD Million; 2019–2032)
    • Single-Pack
    • Multi-Pack
  • Indication Outlook (Revenue, USD Million; 2019–2032)
    • Dehydration
    • Diarrhea
    • Gastroenteritis
    • Electrolyte Imbalance
    • Others
  • Age Group Outlook (Revenue, USD Million; 2019–2032)
    • Pediatric and Children
    • Adults
  • Distribution Channel Outlook (Revenue, USD Million; 2019–2032)
    • Online
      • E-Commerce Websites
      • Online/Mail-Order Pharmacies
    • Offline
      • Hospital Pharmacies
      • Retailers/Distributors
      • Others
  • Regional Outlook (Revenue, USD Million; 2019-2032)
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K.
      • Italy
      • Spain
      • Benelux
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • South Korea
      • Rest of APAC
    • Latin America
      • Brazil
      • Rest of LATAM
    • Middle East & Africa
      • Saudi Arabia
      • UAE
      • South Africa
      • Turkey
      • Rest of MEA

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Read our Press Release @ https://www.emergenresearch.com/press-release/global-oral-rehydration-salts-market

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.